Back to search

National and Kapodistrian University of Athens

Μελέτη μεταγραφικών παραγόντων ανάπτυξης σε αλλοιώσεις του τραχήλου της μήτρας γυναικών κατά την εμμηνόπαυση

Abstract

dc:description

The Papanikolaou test has reduced the morbidity caused by cervical cancer since its implementation. Despite that, there are some limitations concerning its sensitivity , that cause problems in its diagnostical usefulness. Various methods have been proposed to reduce this phenomenon. Among them, researchers propose the use of specific biological markers, which they can identify the dysplastic and neoplastic cells.In our study, we examined the use of p16INK4a and cerbB2 as biomarkers for cervical dysplastic and neoplastic lesions. We decided to do so, because of their known biological role in cases of other organs’ neoplasias.Our results showed the following:1) p16INK4a protein is expressed in 54,5% of the cases of cervical carcinoma (derived by squamous cells), in 28,8% of the cases caracterized by the presence of ASCUS and is not expressed in none of the cases caracterized by increased maturation.2) There is a correlation of the intensity of p16INK4a staining with the diagnosis. In cases of cervical cancer , the 66,7% is stained very intensively, whereas 33,3% is stained lightly. In ASCUS cases , the 35,3% is stained intensively, whereas the 64,7% is stained lightly. In cases of increased maturation, there is no p16INK4a staining at all.3) ln all diagnostical categories we observed that aging caused decreased expression of p16INK4a .To be more specific, we observed that by dividing our specimens in 3 categories (<60 years, between 60 and 70 years and >70 years) in ASCUS diagnostic category the positive expression of p16INK4a was 35,7% in the first group, 22,2% in the third group and 0% in the third group respectively. In cases of cervical cancer the results were 0% for the first, 75% for the second and 60% for the third group. That clearly shows that, excluding the category of the first group of patients with carcinoma, there is a decreased expression of p16INK4a by the aging of the patients4) The c-erbB-2 gene is expressed in 60,2% of all cases whereas in 39,8% it is not expressed5) The c-erbB-2 gene is expressed in 64,3% of the cases of increasedmaturation, in 54,23% of the cases caracterized by the presence of ASCUS cells and in 81,8% of the cases of cervical cancer 6) Main target of our study was to compare the expression of p16INK4a and c- erbB-2 in all cases of dysplastic and neoplastic lesions. We examined a greater expression of the c-erbB-2 gene than that of p16INK4a gene. So ,in cases of increased maturation , p16INK4a is not expressed at all, whereas c- erbB-2 is expressed in 64,3% of the studied cases. In ASCUS cases, c-erbB- 2 is expressed in 54,23% of the cases, whereas p16INK4a is expressed in 28,8% of the cases. In cases of cervical cancer, c-erbB-2is expressed in 81,8% of the cases; in contrast, p16INK4a gene is expressed in 54,5% of the examined cases7) As we previously mentioned, c-erbB-2 is expressed more than p16INK4a. That is better shown in the analysis of the two genes expression in correlation with age.In cases of increased maturation , in the age group of <60 years c-erbB-2 is expressed in 50% of the cases, in the age group of 60-70 years is expressed in 80% of the cases and in the age group of >70 years is expressed in 100% of the cases. In these cases (of increased maturation) p16INK4a is not expressed at all.In ASCUS cases ,c-erbB-2 gene is expressed in 61,9% in the age group of <60 years , in the age group of 60-70 years is expressed in 22,2% of the cases and in the age group of >70 years is expressed in 50% of the cases. In these cases , p16INK4a is expressed in 35,7% in the age group of <60 years , in the age group of 60-70 years is expressed in 22,2% of the cases and in the age group of >70 years is not expressed at all.In the cases of cervical cancer, c-erbB-2 gene is expressed in 100% in the age group of <60 years , in the age group of 60-70 years is expressed in 100% of the cases and in the age group of >70 years is expressed in 60% of the cases. In these cases , p16INK4a is expressed in 0% in the age group of <60 years , in the age group of 60-70 years is expressed in 75% of the cases and in the age group of >70 years is expressed in 60% of the cases.To sum up, we examined in our study the expression of the two genes in order to use them as biomarkers in dysplastic and neoplastic cases of the uterus cervix. Our study was focused in menopausal women, because we wanted to examine if there are any changes in molecular level in these women that might be affecting the expression of these genes . Despite the fact that our research is internationally original, our results do not differ from those previously published in similar research.By our study, we propose that either c-erbB-2 or p16INK4a can be used in the daily routine of a cytological laboratory in order to help distinguishing dysplastic and neoplastic cells. Their use is easy and the costs relatively low. If there is to choose between them , c-erbB-2 seems to be more sensitive marker than p16INK4a in all dysplastic and neoplastic cases. We plan to examine the use of c-erbB-2 not only as diagnostic measure but also as therapeutic target with our future research.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2006

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kalampokas, Theodoros
  • Καλαμπόκας, Θεόδωρος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24809

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kalampokas, Theodoros; Καλαμπόκας, Θεόδωρος. Μελέτη μεταγραφικών παραγόντων ανάπτυξης σε αλλοιώσεις του τραχήλου της μήτρας γυναικών κατά την εμμηνόπαυση. National and Kapodistrian University of Athens, 2006. http://hdl.handle.net/10442/hedi/24809